The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patients With Psoriatic Arthritis - AcademicCME

The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patients With Psoriatic Arthritis

1.0

Claim your AMA PRA Category 1 Credit or CNE Contact Hour

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

course Faculty

No data was found

Related Courses

Pain Management in Endometriosis: A Primer for NPs and PAs

The (Busy!) Year in Review: The Emergence of Aldosterone Synthase Inhibitors for Difficult...

Cardiometabolic

The (Busy!) Year in Review: The Emergence of Aldosterone Synthase Inhibitors for Difficult...